FDA OKs Warner Chilcott's Atelvia for postmenopausal osteoporosis

10/11/2010 | Reuters

The FDA has approved Atelvia, Warner Chilcott's treatment for osteoporosis in postmenopausal women. The delayed-release tablet belongs to the Actonel family of bone drugs that Warner Chilcott purchased last year from Procter & Gamble.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC